Relationship between striatal glucose consumption and copper excretion in patients with Wilson's disease treated withd-penicillamine

[1]  H. Hefter,et al.  Wilson disease: clinical presentation, treatment, and survival. , 1991, Annals of internal medicine.

[2]  H. Nazer,et al.  Wilson's Disease. , 1991, Annals of Saudi medicine.

[3]  H. Freund,et al.  Does orthotopic liver transplantation heal Wilson's disease? Clinical follow‐up of two liver‐transplanted patients , 1991, Acta neurologica Scandinavica.

[4]  L. Deecke,et al.  Neurological and neuropsychiatric spectrum of Wilson's disease: a prospective study of 45 cases , 1991, Journal of Neurology.

[5]  C. Kirsch,et al.  SPECT imaging of dopamine D2 receptors with 123I‐IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's disease , 1991, Nuclear medicine communications.

[6]  W. Martin,et al.  The nigrostriatal dopaminergic pathway in Wilson's disease studied with positron emission tomography. , 1991, Journal of neurology, neurosurgery, and psychiatry.

[7]  L. Prayer,et al.  Evoked potentials in assessment and follow-up of patients with Wilson's disease , 1990, The Lancet.

[8]  H. Herzog,et al.  Cortical and subcortical glucose consumption measured by PET in patients with Huntington's disease. , 1990, Brain : a journal of neurology.

[9]  I. Scheinberg,et al.  Verbal Recall and Recognition Abilities in Patients with Wilson's Disease , 1989, Cortex.

[10]  A. Goffinet,et al.  Effect of D-penicillamine treatment on brain metabolism in Wilson's disease: a case study. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[11]  I. Scheinberg,et al.  Neuropsychological impairment in Wilson's disease. , 1988, Archives of neurology.

[12]  I. Sternlieb,et al.  Neuropathological findings in penicillamine-treated patients with Wilson's disease. , 1988, Clinical neuropathology.

[13]  C. Marsden.  Wilson's disease. , 1987, The Quarterly journal of medicine.

[14]  J. Mazziotta,et al.  Wilson's disease studied with FDG and positron emission tomography , 1987, Neurology.

[15]  J. Walshe,et al.  BRAIN COPPER IN WILSON'S DISEASE , 1987, The Lancet.

[16]  M. Rosselli,et al.  Wilson's disease, a reversible dementia: case report. , 1987, Journal of clinical and experimental neuropsychology.

[17]  T. Saito,et al.  Presenting symptoms and natural history of Wilson disease , 1987, European Journal of Pediatrics.

[18]  A. Young,et al.  Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging. , 1987, Archives of neurology.

[19]  J S Fowler,et al.  Positron Emission Tomography and Computed Tomography Assessments of the Aging Human Brain , 1984, Journal of computer assisted tomography.

[20]  B. Reisberg,et al.  Computed Tomography and Positron Emission Transaxial Tomography Evaluations of Normal Aging and Alzheimer's Disease , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  R A Margolin,et al.  Cerebral glucose utilization, as measured with positron emission tomography in 21 resting healthy men between the ages of 21 and 83 years. , 1983, Brain : a journal of neurology.

[22]  F. J. Williams,et al.  Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents. , 1981, Brain : a journal of neurology.

[23]  G. Lanzi,et al.  Computerized cranial tomography in Wilson disease: report of a case before and after penicillamine therapy. , 1981, The Italian journal of neurological sciences (Testo stampato).

[24]  S. A. Wilson,et al.  PROGRESSIVE LENTICULAR DEGENERATION: A FAMILIAL NERVOUS DISEASE ASSOCIATED WITH CIRRHOSIS OF THE LIVER , 1912 .

[25]  H. Herzog,et al.  Regional cerebral glucose consumption measured by positron emission tomography in patients with Wilson's disease , 2004, European Journal of Nuclear Medicine.

[26]  H. Imhof,et al.  Cranial MRI in Wilson's disease , 2004, Neuroradiology.

[27]  H. Herzog,et al.  11 – Regional cerebral metabolic rate of glucose measured by 18F-DG PET in Huntington's disease, benign hereditary chorea and Wilson's disease , 1990 .

[28]  R. Bornstein,et al.  Neuropsychological and electrophysiological examination of a patient with Wilson's disease. , 1985, The International journal of neuroscience.

[29]  Scheinberg Ih.  Wilson's disease. , 1981 .

[30]  W. Dobyns,et al.  Clinical spectrum of Wilson's disease (hepatolenticular degeneration). , 1979, Mayo Clinic proceedings.